Austin, TX, United States of America

Leo Ma

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leo Ma. Retrieved from https://idiyas.com/inventor/leo-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Leo Ma

Introduction

Leo Ma is an accomplished inventor based in Austin, Texas. He has made significant contributions to the field of optical coherence tomography, particularly in the detection and treatment of cells. His innovative work has the potential to impact various medical applications.

Latest Patents

Leo Ma holds a patent titled "Optical coherence tomographic detection of cells and killing of the same." This patent outlines systems, methods, and compositions for utilizing optical coherence tomography to detect cells and subsequently kill those detected cells. The process involves applying energy to a particle comprised by the cell, which can lead to the injury or death of the cell.

Career Highlights

Leo Ma is affiliated with The University of Texas System, where he continues to advance his research and innovations. His work in optical coherence tomography has garnered attention for its potential applications in medical diagnostics and treatment.

Collaborations

Throughout his career, Leo has collaborated with notable colleagues, including Marc D. Feldman and Thomas E. Milner. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Leo Ma's contributions to the field of optical coherence tomography exemplify the impact of innovation in medical technology. His work not only enhances our understanding of cell detection but also opens new avenues for treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…